Paul Stuka - May 17, 2023 Form 4 Insider Report for InspireMD, Inc. (NSPR)

Role
Director
Signature
/s/ Craig Shore, Attorney-in-Fact for Paul Stuka
Stock symbol
NSPR
Transactions as of
May 17, 2023
Transactions value $
$0
Form type
4
Date filed
5/19/2023, 04:15 PM
Previous filing
May 16, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NSPR Common Stock Award $0 +226K +533.27% $0.00 268K May 17, 2023 Direct F1
holding NSPR Common Stock 249K May 17, 2023 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NSPR Options to purchase common stock (right to buy) Award $0 +75.2K +536.98% $0.00 89.2K May 17, 2023 Common Stock 75.2K $1.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.
F2 These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F3 The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.